Loading...
XFRABZ7A
Market cap4.51bUSD
Dec 20, Last price  
5.35EUR
1D
0.00%
1Q
-27.21%
Name

Bumrungrad Hospital PCL

Chart & Performance

D1W1MN
XFRA:BZ7A chart
P/E
21.59
P/S
5.98
EPS
8.82
Div Yield, %
69.12%
Shrs. gr., 5y
—
Rev. gr., 5y
6.66%
Revenues
25.38b
+22.47%
5,809,299,0206,806,775,1187,895,517,6509,413,122,5598,881,828,8179,337,855,78010,068,958,69111,014,830,03812,982,543,56814,345,985,94915,629,691,66117,660,405,90017,914,672,82318,346,237,77818,325,961,83218,474,311,76412,362,100,37012,460,420,94220,720,563,65525,376,158,560
Net income
7.01b
+41.88%
934,547,1151,052,739,2791,095,702,1001,605,462,2011,191,046,6101,245,648,4401,258,494,6821,588,031,7062,666,731,3462,520,782,2692,730,296,1493,435,833,6133,626,173,9333,943,889,2074,151,885,6843,747,729,2951,204,137,5721,215,678,2264,938,221,8507,006,450,979
CFO
7.09b
+14.19%
1,177,917,8421,512,742,8151,137,023,1021,340,654,7161,762,404,2931,707,407,5831,649,259,1841,878,740,8153,024,551,7043,274,259,2393,890,303,1063,987,408,2835,173,643,8835,243,379,0354,733,929,0074,897,346,4092,260,525,4683,556,157,9726,212,622,2817,094,364,455
Dividend
Aug 23, 20240.05254 EUR/sh
Earnings
Feb 20, 2025

Profile

Bumrungrad Hospital Public Company Limited owns and operates healthcare-related entities in Thailand and internationally. The company offers diagnostic, therapeutic, and intensive care facilities in a medical center. Its outpatient clinics/centers include allergy, arrhythmia, behavioral health, breastfeeding, breast care, children, dental, diabetes, diagnostic, dialysis, digestive disease, emergency, eye, fertility and IVF, health screening, hearing and balance, heart valve, cancer, hyperbaric oxygen therapy, hypertension, joint replacement, liver, memory, men, nephrology, neuroscience, new life healthy aging, orthopedic, Parkinson's disease and movement disorders, perinatal, physical therapy and rehabilitation, plastic surgery, pulmonary, refractive surgery, robotic scoliosis and surgery, skin, sleep lab, spine, sports medicine and lifestyle, surgical, travel medicine, urology, vitalife, and women's, as well as ear, nose, and throat centers. In addition, the company is involved in the real estate assets holding activities; provision of clinical research services; distribution of pharmaceutical and medical goods in specialized stores; operation of personnel development and training center for healthcare services; and patient referral service business. It operates 580 beds and approximately 56 clinics/centers. The company was founded in 1980 and is headquartered in Bangkok, Thailand.
URL
https://www.bumrungrad.com
IPO date
Dec 15, 1989
Employees
Domiciled in
TH
Incorporated in
TH

Valuation

Title
THB in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
25,376,159
22.47%
20,720,564
66.29%
12,460,421
0.80%
Cost of revenue
17,074,978
14,897,204
11,026,886
Unusual Expense (Income)
NOPBT
8,301,181
5,823,359
1,433,535
NOPBT Margin
32.71%
28.10%
11.50%
Operating Taxes
1,582,524
1,072,193
215,847
Tax Rate
19.06%
18.41%
15.06%
NOPAT
6,718,657
4,751,166
1,217,688
Net income
7,006,451
41.88%
4,938,222
306.21%
1,215,678
0.96%
Dividends
(2,938,460)
(2,542,653)
(2,544,865)
Dividend yield
1.53%
1.38%
2.08%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
16,960
23,579
40,489
Long-term debt
141,107
78,838
125,036
Deferred revenue
2
Other long-term liabilities
853,653
797,198
895,999
Net debt
(10,672,044)
(8,175,455)
(5,771,741)
Cash flow
Cash from operating activities
7,094,364
6,212,622
3,556,158
CAPEX
(1,572,190)
(1,220,606)
(969,241)
Cash from investing activities
(2,428,594)
(3,222,521)
2,252,063
Cash from financing activities
(3,050,793)
(2,656,112)
(5,255,447)
FCF
4,542,473
4,582,958
2,100,353
Balance
Cash
10,745,479
8,276,163
5,935,597
Long term investments
84,632
1,708
1,669
Excess cash
9,561,303
7,241,843
5,314,245
Stockholders' equity
23,327,935
19,235,464
17,074,563
Invested Capital
15,481,283
13,007,283
13,156,033
ROIC
47.17%
36.32%
8.85%
ROCE
33.15%
28.76%
7.76%
EV
Common stock shares outstanding
867,415
867,415
867,415
Price
222.00
4.72%
212.00
50.35%
141.00
17.50%
Market cap
192,566,130
4.72%
183,891,980
50.35%
122,305,515
17.50%
EV
182,191,627
176,017,229
116,866,775
EBITDA
9,397,949
6,940,234
2,613,456
EV/EBITDA
19.39
25.36
44.72
Interest
2,394
3,547
119,756
Interest/NOPBT
0.03%
0.06%
8.35%